| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| SYNLOGIC, INC. | Director | Stock Option (right to buy) | 30K | Jun 22, 2023 | Direct | ||
| Eiger BioPharmaceuticals, Inc. | Director | Stock Option (Right to Buy) | 28K | Mar 1, 2023 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
|---|---|---|---|---|---|---|---|
| SYBX | SYNLOGIC, INC. | Jun 22, 2023 | 1 | $0 | 4 | Jun 26, 2023 | Director |
| EIGR | Eiger BioPharmaceuticals, Inc. | Mar 1, 2023 | 1 | $0 | 4 | Mar 3, 2023 | Director |
| EIGR | Eiger BioPharmaceuticals, Inc. | Jul 18, 2022 | 1 | $0 | 4 | Jul 19, 2022 | Director |
| EIGR | Eiger BioPharmaceuticals, Inc. | Jul 18, 2022 | 0 | $0 | 3 | Jul 19, 2022 | Director |
| SYBX | SYNLOGIC, INC. | Jun 9, 2022 | 1 | $0 | 4 | Jun 13, 2022 | Director |
| SYBX | SYNLOGIC, INC. | Jun 10, 2021 | 1 | $0 | 4 | Jun 14, 2021 | Director |